These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7579984)

  • 1. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour.
    Kiernan C; Reeves D; Alborz A
    J Intellect Disabil Res; 1995 Aug; 39 ( Pt 4)():263-74. PubMed ID: 7579984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prescribing of neuroleptic drugs for people with learning disabilities living in Leicestershire.
    Branford D; Collacott RA; Thorp C
    J Intellect Disabil Res; 1995 Dec; 39 ( Pt 6)():495-500. PubMed ID: 8746736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The form and function of challenging behaviours.
    Emerson E; Bromley J
    J Intellect Disabil Res; 1995 Oct; 39 ( Pt 5)():388-98. PubMed ID: 8555715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities.
    Oliver-Africano P; Dickens S; Ahmed Z; Bouras N; Cooray S; Deb S; Knapp M; Hare M; Meade M; Reece B; Bhaumik S; Harley D; Piachaud J; Regan A; Ade Thomas D; Karatela S; Rao B; Dzendrowskyj T; Lenôtre L; Watson J; Tyrer P
    J Intellect Disabil Res; 2010 Jan; 54(1):17-25. PubMed ID: 19627427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Shetty M; Barnhill J; Elamir B; Davis JM
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):37-48. PubMed ID: 15482629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults.
    Janowsky DS; Barnhill LJ; Shetty M; Davis JM
    J Clin Psychopharmacol; 2005 Feb; 25(1):19-25. PubMed ID: 15643096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs and emotional reactions of care staff working with people with challenging behaviour.
    Bromley J; Emerson E
    J Intellect Disabil Res; 1995 Aug; 39 ( Pt 4)():341-52. PubMed ID: 7579992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: Aggressive challenging behaviour in adults with intellectual disability following community resettlement.
    Bhaumik S; Watson JM; Devapriam J; Raju LB; Tin NN; Kiani R; Talbott L; Parker R; Moore L; Majumdar SK; Ganghadaran SK; Dixon K; Das Gupta A; Barrett M; Tyrer F
    J Intellect Disabil Res; 2009 Mar; 53(3):298-302. PubMed ID: 19250390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.
    Deb S; Farmah BK; Arshad E; Deb T; Roy M; Unwin GL
    Res Dev Disabil; 2014 Mar; 35(3):711-25. PubMed ID: 24405794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study on the prevalence of challenging behaviours.
    Chung MC; Cumella S; Bickerton WL; Winchester C
    Psychol Rep; 1996 Dec; 79(3 Pt 2):1427-30. PubMed ID: 9009800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the long term efficacy of antipsychotic drugs in controlling the behavior of institutionalized retardates.
    Zimmermann RL; Heistad GT
    J Am Acad Child Psychiatry; 1982 Mar; 21(2):136-43. PubMed ID: 6121828
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.
    Schroeder SR; Rojahn J; Reese RM
    J Autism Dev Disord; 1997 Feb; 27(1):89-102. PubMed ID: 9018584
    [No Abstract]   [Full Text] [Related]  

  • 17. Tranquilizer reduction trials in a residential program for persons with mental retardation.
    Spreat S; Serafin C; Behar D; Leiman S
    Hosp Community Psychiatry; 1993 Nov; 44(11):1100-2. PubMed ID: 7904579
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire.
    Branford D
    J Intellect Disabil Res; 1996 Aug; 40 ( Pt 4)():358-68. PubMed ID: 8884591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine in the management of persistent destructive behaviour in a 17-year-old boy with intellectual disability.
    Dadlani N; Small J; Starling J; Einfeld S
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.